Population Pharmacokinetic Modeling of Sertraline Treatment in Alzheimer’s Disease Patients: The DIADS-2 Study

dc.contributor.authorLi, Claire H.
dc.contributor.authorPollock, Bruce G.
dc.contributor.authorLyketsos, Constantine G.
dc.contributor.authorVaidya, Vijay
dc.contributor.authorDrye, Lea T.
dc.contributor.authorKirshner, Margaret
dc.contributor.authorSorisio, Denise
dc.contributor.authorBies, Robert R.
dc.contributor.authorDIADS-2 Research Group
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2025-05-22T09:52:12Z
dc.date.available2025-05-22T09:52:12Z
dc.date.issued2013
dc.eprint.versionAuthor's manuscript
dc.identifier.citationLi CH, Pollock BG, Lyketsos CG, et al. Population pharmacokinetic modeling of sertraline treatment in patients with Alzheimer disease: the DIADS-2 study. J Clin Pharmacol. 2013;53(2):234-239. doi:10.1177/0091270012445793
dc.identifier.urihttps://hdl.handle.net/1805/48310
dc.language.isoen_US
dc.publisherWiley
dc.relation.isversionof10.1177/0091270012445793
dc.relation.journalJournal of Clinical Pharmacology
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectAlzheimer disease
dc.subjectAntidepressive agents
dc.subjectDepression
dc.subjectSertraline
dc.titlePopulation Pharmacokinetic Modeling of Sertraline Treatment in Alzheimer’s Disease Patients: The DIADS-2 Study
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Li2013Population-AAM.pdf
Size:
322.6 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: